Neurogenic lower urinary tract dysfunction is where urology stops being about symptoms and starts being about protecting kidneys. Some of these patients feel fine and are silently destroying their upper tracts.
30 pathway steps3 pathways1 local-policy steps
Your learning progress0 of 31 chapters complete
Saved privately in this browser and shared across state tabs.
Didactics
Shared across all locations
Neurogenic lower
urinary tract dysfunction is where urology stops being about symptoms
and starts being about protecting kidneys. Some of these patients
feel fine and are silently destroying their upper tracts.
Understanding the neuro-anatomy lets you predict the bladder's
behavior from the level of the lesion — and understanding
urodynamics lets you prove it.
25.1 The wiring, simplified
Pathway
Origin
Action
Parasympathetic (pelvic nerve)
S2–S4
CONTRACTS the detrusor — the “emptying” nerve.
Acetylcholine on M3 receptors
Sympathetic (hypogastric nerve)
T10–L2
RELAXES the detrusor (beta-3) and CONTRACTS the bladder neck
(alpha-1) — the “storage” nerve
Somatic (pudendal nerve)
S2–S4 (Onuf's nucleus)
Contracts the EXTERNAL sphincter — voluntary control
Pontine micturition center
Brainstem
The coordinator — ensures the sphincter RELAXES exactly when
the detrusor CONTRACTS
The critical
inference: any lesion ABOVE the pons leaves coordination intact (the
sphincter still relaxes appropriately) — so you get an overactive
bladder but a SAFE one. Any lesion BETWEEN the pons and the sacral
cord destroys coordination — the detrusor contracts against a
closed sphincter. That is detrusor-sphincter dyssynergia (DSD), and
it generates dangerously high bladder pressures. Lesions BELOW the
sacral cord denervate the bladder entirely — a flaccid, areflexic
bladder that does not empty.
25.2 Predict the bladder from the lesion
Lesion level
Examples
Expected bladder behavior
Upper-tract risk
Suprapontine (above the brainstem)
Stroke, Parkinson's, dementia, brain tumor
Detrusor overactivity WITH coordinated sphincter — urgency and
urge incontinence; empties well
Areflexic, flaccid, acontractile detrusor — retention, overflow
incontinence, high residuals
MODERATE — from chronic retention and infection
The one thing that will kill your patient
SPINAL SHOCK: immediately
after an acute spinal cord injury there is a period (weeks to
months) of complete areflexia — a flaccid bladder —
regardless of the eventual pattern. Do not diagnose the long-term
bladder type during spinal shock. Drain the bladder and wait.
DETRUSOR-SPHINCTER
DYSSYNERGIA is the enemy. Sustained detrusor pressures above ~40
cm H2O — and poor bladder compliance — transmit backward to
the kidneys, causing hydronephrosis, reflux, and renal failure.
The patient may have NO symptoms while this happens.
AUTONOMIC DYSREFLEXIA: in a patient with a cord lesion at
or above T6, a noxious stimulus below the level (a distended
bladder, a blocked catheter, a full rectum, a cystoscopy)
triggers a massive unopposed sympathetic surge — SEVERE
hypertension, pounding headache, sweating and flushing above the
lesion, and reflex bradycardia. It can cause stroke and death.
TREATMENT: sit the patient UP, remove the stimulus (unkink/drain
the catheter FIRST — that is the cause 80%+ of the time), and
give a fast-acting antihypertensive (nifedipine, nitroglycerin)
if the BP remains dangerously high. Never do a bladder procedure
on a high-cord patient without anticipating this.
25.3 Management principles
The goals, in
strict priority order: (1) protect the kidneys, (2) prevent
infection, (3) achieve continence, (4) preserve quality of life and
independence. Never trade renal protection for convenience.
Keep
storage pressures LOW. This is the whole ballgame. A safe
bladder is a low-pressure reservoir that empties completely and
regularly.
Clean
intermittent catheterization (CIC) is the gold standard for
emptying. Typically every 4–6 hours, keeping catheterized
volumes under ~400–500 mL. It has a far lower infection and
complication rate than an indwelling catheter and preserves
independence.
To lower
storage pressure: a beta-3 agonist (our preferred oral agent —
Chapter 5), intradetrusor onabotulinumtoxinA (highly effective in
neurogenic detrusor overactivity, and often used at 200 units in
this population), and, if refractory, bladder augmentation
(augmentation cystoplasty).
To
improve emptying: CIC is the answer. Alpha-blockers help
modestly with bladder-neck relaxation. Do NOT rely on Credé or
Valsalva voiding in a patient with DSD — you are forcing urine
against a closed sphincter and driving pressure into the kidneys.
Sacral
neuromodulation (InterStim): an important option for selected
patients, particularly non-obstructive urinary retention (including
Fowler's syndrome) and refractory neurogenic overactivity in
patients with incomplete lesions. our practice's InterStim Center of
Excellence experience is directly relevant here (Chapter 5).
Avoid the
chronic indwelling urethral catheter wherever possible — it
causes urethral erosion (a “patulous” destroyed urethra),
stones, recurrent infection, and, with decades of use, squamous cell
carcinoma of the bladder. A suprapubic tube is the better long-term
choice when a catheter is truly unavoidable.
Lifelong
surveillance is mandatory: periodic renal ultrasound,
creatinine, and — in high-risk patients — repeat urodynamics.
These patients are followed forever, and they will not tell you
their kidneys are failing.
25.4 Urodynamics — what it is and how to read
it
Urodynamics (UDS)
is a functional test that reproduces the patient's symptoms while
measuring pressures — it answers questions that no symptom score,
flow rate, or ultrasound can. It is not a screening test; order it
with a specific question in mind.
Make it simple: filling and emptying
Phase 1
Filling = 3 C’s + S
Capacity — how much does the bladder hold?
Compliance — does pressure stay low as volume rises?
Contractions — are there involuntary detrusor contractions?
Sensation — when does the patient first feel filling, desire to void, and strong desire?
Never interpret low flow by itself. Pair the flow with detrusor pressure.
When to order it
Neurogenic
bladder (to assess storage pressure and upper-tract risk — the
most important indication).
Before
invasive therapy for incontinence or obstruction, when the diagnosis
is not clear-cut.
When the
symptoms and the objective findings do not match, or after a failed
prior treatment.
Suspected
bladder-outlet obstruction in a man whose story is atypical, or in
any woman (obstruction is rare in women and needs proof).
Suspected
detrusor underactivity — distinguishing “the pump is broken”
from “the pipe is blocked,” because the treatment is opposite
and the pressure-flow study is the ONLY way to tell.
The components
Component
What it measures
What you learn
Uroflowmetry
Voided volume over time (free flow)
Qmax and the curve shape. A normal Qmax > 15 mL/s. A flat,
prolonged “plateau” curve suggests a STRICTURE; an
interrupted curve suggests abdominal straining. Needs a voided
volume > 150 mL to be valid
Filling cystometry (CMG)
Bladder pressure during filling (Pves), abdominal pressure
(Pabd), and detrusor pressure (Pdet = Pves − Pabd)
Sensation, capacity, COMPLIANCE (Δvolume/Δpressure — a stiff,
non-compliant bladder is dangerous), and involuntary DETRUSOR
OVERACTIVITY contractions
Pressure-flow study
Detrusor pressure DURING voiding, plotted against flow
The definitive test for obstruction. HIGH pressure + LOW flow =
OBSTRUCTION. LOW pressure + LOW flow = DETRUSOR UNDERACTIVITY.
This single distinction changes management completely
EMG (patch electrodes)
External sphincter activity
Sphincter activity should FALL as the detrusor contracts. If EMG
activity RISES during a detrusor contraction, that is
DETRUSOR-SPHINCTER DYSSYNERGIA
Videourodynamics (with fluoroscopy)
All of the above plus real-time imaging
The gold standard in neurogenic patients — shows vesicoureteral
reflux, bladder-neck behavior, the level of obstruction, and
diverticula
Reading a tracing — filling first, then emptying
Check
the quality first: are the pressure lines responding to a cough? If
the cough spike does not appear on both Pves and Pabd, the study is
not valid and nothing you read from it is real.
Read the
FILLING phase as 3 C’s + S: capacity,
compliance, involuntary contractions,
and sensation. Rising Pdet with filling means poor
compliance. Sharp phasic rises are involuntary detrusor contractions.
Record when sensation begins and how it changes as the bladder fills.
Look at the
leak: did the patient leak with a cough (stress incontinence) or
with a detrusor contraction (urgency incontinence)? Note the
detrusor leak point pressure — a DLPP above ~40 cm H2O predicts
upper-tract deterioration.
Read the
EMPTYING phase by pairing pressure with flow. High
pressure + low flow = obstruction. Low pressure + low flow = detrusor
underactivity or impaired contractility. Do not diagnose the cause of
low flow from the flow rate alone.
Check the
EMG: does the sphincter relax during the void, or does it fire
(dyssynergia)?
Finally, ask
the only question that matters: did the study REPRODUCE the
patient's actual complaint? If it did not, be cautious about acting
on it.
Urodynamics pearls
UDS is provocative and
uncomfortable, and it carries a real risk of UTI — send a
sterile urine to the study and consider prophylaxis.
A high detrusor leak point
pressure (> 40 cm H2O) or poor compliance is a RENAL emergency
in slow motion — it demands treatment even in an asymptomatic
patient.
In a high-cord patient, be
prepared for autonomic dysreflexia during the study. Monitor
blood pressure throughout.
The UroCuff test is a non-invasive alternative that
estimates bladder pressure using a penile cuff — useful for
screening for obstruction in men without a catheterized study.
25.5 Sample reports — learn the pattern, then read the numbers
Synthetic teaching examples — not patient records and not for diagnosis. The values and traces below are illustrative. Always confirm test quality, whether the void was representative, and the complete clinical context before acting on a report.
Synthetic teaching example
Uroflow + PVR report
Not a patient record
Measure
Result
Voided volume
310 mL
Maximum flow, Qmax
18 mL/s
Average flow
10 mL/s
Time to Qmax
7 seconds
Flow / voiding time
31 / 32 seconds
Post-void residual
35 mL
Patient report
Representative of usual void
Sample impression: Technically adequate, representative void with an adequate voided volume, smooth bell-shaped curve, and low residual. This is a reassuring study. Uroflow is used to diagnose obstruction by assessing Qmax and curve shape alongside voided volume and PVR.
Read in this order: voided volume → curve shape → Qmax → PVR → whether it felt usual.
A low-volume or nonrepresentative void can make the numbers misleading; repeat it rather than over-interpreting it.
What does UroCuff interruption pressure mean?
1The patient voids
Urine flow is measured while the patient voids naturally.
→
2The cuff inflates
The penile cuff gradually increases pressure until urine flow stops.
→
3Flow is interrupted
The cuff pressure required to stop flow is the interruption pressure. It estimates the pressure the bladder generated at that moment.
Interruption pressure never stands alone. Pair it with flow on the nomogram: high pressure + low flow supports obstruction; low pressure + low flow supports detrusor underactivity or impaired contractility. A high interruption pressure means the bladder generated substantial pressure against the outlet—it does not diagnose obstruction without the accompanying flow result and an adequate-quality test.
Synthetic obstructed example
UroCuff: high pressure + low flow
Not a patient record
Measure
Result
Voided volume
285 mL
Maximum flow, Qmax
8.2 mL/s
Mean cuff interruption pressure
155 cm H2O
Post-void residual
90 mL
Inflations accepted
4 of 4
Device nomogram category
Obstructed
Patient report
Representative of usual void
Sample impression — OBSTRUCTED: Adequate representative study with reproducible flow interruption and recovery. The bladder generated a high mean interruption pressure of 155 cm H2O, yet Qmax remained low at 8.2 mL/s. That high-pressure/low-flow combination falls in the device’s obstructed category and supports bladder-outlet obstruction with pressure generation preserved. Correlate with symptoms, PVR, anatomy, and the treatment decision.
Why this is obstruction: the bladder is pushing hard, but urine still moves slowly—the outlet is resisting flow.
Quality first: accept an inflation only when flow is clearly interrupted and then recovers after cuff release. Several consistent interruption pressures are more credible than one isolated inflation.
Do not confuse pressure with obstruction: a high interruption pressure alone is not enough; the interpretation comes from pressure paired with flow and its position on the nomogram.
UroCuff is an adjunct to conventional uroflow and does not replace invasive urodynamics when the clinical question requires filling pressures, compliance, detrusor overactivity, or a catheterized pressure-flow study.
Synthetic teaching example
Multichannel urodynamics report
Not a patient record
Phase
Finding
Quality
Cough signals concordant; study technically adequate and representative
Filling sensations
First sensation 150 mL; first desire 250 mL; strong desire 370 mL
Capacity / compliance
430 mL / 43 mL per cm H2O
Storage
No detrusor overactivity; no stress leak demonstrated
Pressure-flow
Qmax 7 mL/s; Pdet at Qmax 72 cm H2O
Emptying
Voided 350 mL; PVR 80 mL
EMG
Appropriate sphincter relaxation during voiding
Sample impression: Normal-capacity, compliant bladder without demonstrated detrusor overactivity or stress incontinence. Voiding phase shows a sustained high-pressure, low-flow pattern with sphincter relaxation, consistent with bladder-outlet obstruction rather than detrusor-sphincter dyssynergia. Mild incomplete emptying.
Neurogenic lower urinary tract dysfunction is where urology stops being about symptoms and starts being about protecting kidneys — some of these patients feel fine while silently destroying their upper tracts. Understanding the neuro-anatomy lets you predict the bladder's behavior from the level of the lesion; urodynamics lets you prove it.
The wiring, the three lesion levels and the bladder each produces, and the three things that will hurt your patient.
Select a box to open its teaching details.
The pathways
Parasympathetic (pelvic nerve), S2–S4 — CONTRACTS the detrusor, the "emptying" nerve. Acetylcholine on M3 receptors
Sympathetic (hypogastric nerve), T10–L2 — RELAXES the detrusor (beta-3) and CONTRACTS the bladder neck (alpha-1) — the "storage" nerve
Somatic (pudendal nerve), S2–S4 (Onuf's nucleus) — contracts the EXTERNAL sphincter, voluntary control
Pontine micturition center, brainstem — the coordinator: ensures the sphincter RELAXES exactly when the detrusor CONTRACTS
Ch 25.1 — the wiring, simplified
The inference
ABOVE the pons — coordination intact, sphincter still relaxes appropriately → an overactive but SAFE bladder
BETWEEN the pons and the sacral cord — coordination destroyed; the detrusor contracts against a closed sphincter = detrusor-sphincter dyssynergia (DSD) and dangerously high pressures
BELOW the sacral cord — the bladder is denervated entirely → flaccid, areflexic, does not empty
Ch 25.1 — the critical inference
Predict the bladder from the lesion level
Examples
Stroke
Parkinson's disease
Dementia
Brain tumor
Expected bladder behavior
Detrusor overactivity WITH a coordinated sphincter — urgency and urge incontinence; empties well.
Upper-tract risk
LOW — this is a social problem, not a renal one
Ch 25.2 — predict the bladder from the lesion
Examples
Spinal cord injury
Multiple sclerosis
Transverse myelitis
Expected bladder behavior
Detrusor overactivity WITH detrusor-sphincter dyssynergia (DSD) — high storage pressures, poor emptying, trabeculation.
Upper-tract risk
HIGH — hydronephrosis, reflux, renal failure
The patient may have NO symptoms while this is happening
Ch 25.2 — predict the bladder from the lesion
Examples
Cauda equina
Disc herniation
Pelvic surgery
Diabetic neuropathy
Spina bifida
Expected bladder behavior
Areflexic, flaccid, acontractile detrusor — retention, overflow incontinence, high residuals.
Upper-tract risk
MODERATE — from chronic retention and infection
Ch 25.2 — predict the bladder from the lesion
Time-critical
Spinal shock
Immediately after an acute spinal cord injury there is a period of weeks to months of complete areflexia — a flaccid bladder — regardless of the eventual pattern.
Pitfalls
Labelling a cord-injured patient as having an areflexic bladder during spinal shock and planning long-term management around it
Drain the bladder and wait for the pattern to declare itself
Ch 25.2 — the one thing that will kill your patient
The threshold
Sustained detrusor pressures above ~40 cm H2O — and poor bladder compliance — transmit backward to the kidneys
Consequences
Hydronephrosis
Vesicoureteral reflux
Renal failure
Pitfalls
The patient may have NO symptoms while this happens — you cannot wait for a complaint
Ch 25.2 — the one thing that will kill your patient
Time-critical
Trigger
In a patient with a cord lesion at or above T6, a noxious stimulus below the level — a distended bladder, a blocked catheter, a full rectum, a cystoscopy — triggers a massive unopposed sympathetic surge.
Signs
SEVERE hypertension
Pounding headache
Sweating and flushing above the lesion
Reflex bradycardia
Treatment
Sit the patient UP
Remove the stimulus — unkink or drain the catheter FIRST; that is the cause 80%+ of the time
Give a fast-acting antihypertensive (nifedipine, nitroglycerin) if the BP remains dangerously high
Pitfalls
Never do a bladder procedure on a high-cord patient without anticipating this
Ch 25.2 — the one thing that will kill your patient
Why
Neurogenic bladder — assessing storage pressure and upper-tract risk — is the most important indication for urodynamics.
Next
Work the Urodynamics track for when to order it, what the components tell you, and how to read the tracing.
Ch 25.4 — when to order it
Goals in strict priority order, keeping storage pressure low, emptying with CIC, and lifelong surveillance.
Select a box to open its teaching details.
The goals, in strict priority order
1. Protect the kidneys
2. Prevent infection
3. Achieve continence
4. Preserve quality of life and independence
The rule
Never trade renal protection for convenience.
Ch 25.3 — management principles
What a safe bladder looks like
Low pressure during storage
Empties completely
Empties regularly
The number that defines danger
Sustained detrusor pressure > ~40 cm H2O, or poor compliance, threatens the upper tracts
Ch 25.3 — management principles
Dosing
Typically every 4–6 hours
Keep catheterized volumes under ~400–500 mL
Why CIC
Far lower infection and complication rate than an indwelling catheter
Preserves independence
Ch 25.3 — management principles
Our protocol
A beta-3 agonist is our preferred oral agent for lowering storage pressure (Chapter 5)
Ch 25.3 — to lower storage pressure
Dosing
Intradetrusor onabotulinumtoxinA, often used at 200 units in this population
If refractory
Bladder augmentation (augmentation cystoplasty)
Ch 25.3 — to lower storage pressure
Pitfalls
Credé and Valsalva voiding in DSD drive pressure into the kidneys — do not use them
CIC is the answer for emptying
What does help modestly
Alpha-blockers — modest help with bladder-neck relaxation
Ch 25.3 — to improve emptying
Local policy
Our protocol
our practice's InterStim Center of Excellence experience is directly relevant here (Chapter 5)
Best candidates
Non-obstructive urinary retention, including Fowler's syndrome
Refractory neurogenic overactivity in patients with incomplete lesions
Ch 25.3 — sacral neuromodulation
What a chronic urethral catheter causes
Urethral erosion — a "patulous", destroyed urethra
Stones
Recurrent infection
With decades of use, squamous cell carcinoma of the bladder
Better option
A suprapubic tube when a catheter is truly unavoidable
Ch 25.3 — management principles
Surveillance
Periodic renal ultrasound
Creatinine
Repeat urodynamics in high-risk patients
Pitfalls
These patients are followed forever — a discharged neurogenic bladder patient is a future dialysis patient
Ch 25.3 — lifelong surveillance
Not a screening test — order it with a specific question, then read the tracing in a fixed sequence.
Select a box to open its teaching details.
When to order it
Neurogenic bladder — to assess storage pressure and upper-tract risk. The most important indication
Before invasive therapy for incontinence or obstruction, when the diagnosis is not clear-cut
When symptoms and objective findings do not match, or after a failed prior treatment
Suspected bladder-outlet obstruction in a man with an atypical story, or in any woman — obstruction is rare in women and needs proof
Suspected detrusor underactivity — "the pump is broken" vs. "the pipe is blocked"
Pitfalls
UDS is not a screening test
Ch 25.4 — when to order it
Before the study
Send a sterile urine
Consider prophylaxis
High-cord patients
Be prepared for autonomic dysreflexia during the study